Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02788955Not ApplicableCompleted

Protein Recommendation to Increase Muscle

Role: collaborator

NCT03234790Not ApplicableCompleted

Human Study to Develop a Signature of Occupational Diesel Exhaust Exposure

Role: collaborator

NCT03572101Completed

Living With Colorectal Cancer: Patient and Caregiver Experience

Role: collaborator

NCT04329611Phase 3Terminated

ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease

Role: collaborator

NCT01278992Phase 2Unknown

Rhodiola Rosea for Mental and Physical Fatigue

Role: lead

All 5 trials loaded